A census of human cancer genes

The Pfam Protein Families Database

Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884

A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase

Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785

A cell cycle regulator potentially involved in genesis of many tumor types

Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751

PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992

A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680

Genome‐wide transcriptome analyses reveal p53 inactivation mediated loss of miR‐34a expression in malignant peripheral nerve sheath tumours

Subramanian, S., Thayanithy, V., West, R. B., Lee, C., Beck, A. H., Zhu, S., Downs-Kelly, E. P., Montgomery, K. D., Goldblum, J. R., Hogendoorn, P. C. W., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2633 · Cited by 120

Exon identity crisis: disease-causing mutations that disrupt the splicing code

Sterne-Weiler, T., & Sanford, J. R. (2014) · Genome biology · doi:10.1186/gb4150 · Cited by 123

Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia

Tzoneva, G., Dieck, C. L., Oshima, K., Ambesi‐Impiombato, A., Sánchez-Martín, M., Madubata, C. J., Khiabanian, H., Yu, J., Waanders, E., Iacobucci, I., et al. (2018) · Nature · doi:10.1038/nature25186 · Cited by 117

Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis

Zheng, C., Li, L., Haak, M., Brors, B., Frank, O., Giehl, M., Fabarius, A. C., Schatz, M. C., Weisser, A., Lorentz, C., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404227 · Cited by 117

To die or grow: Parkinson's disease and cancer

WEST, A., DAWSON, V, & DAWSON, T. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.05.002 · Cited by 117

Molecular Characterization of the Pediatric Preclinical Testing Panel

Neale, G. A. M., Su, X., Morton, C. L., Phelps, D. A., Gorlick, R. G., Lock, R. B., Reynolds, C. P., Maris, J. M., Friedman, H. S., Dome, J. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5090 · Cited by 117

DEGAS: De Novo Discovery of Dysregulated Pathways in Human Diseases

Ulitsky, I., Krishnamurthy, A., Karp, R. M., & Ron Shamir, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013367 · Cited by 116

In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma

Chen, J., Hung, W.-S., Chan, H.-H., Tsai, S., & Sun, H. S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts715 · Cited by 116

PTEN opposes negative selection and enables oncogenic transformation of pre-B cells

Shojaee, S., Chan, L. N., Buchner, M., Cazzaniga, V., Cosgun, K. N., Geng, H., Qiu, Y. H., Minden, M. D.-V., Ernst, T., Hochhaus, A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4062 · Cited by 118

Bayesian inference of negative and positive selection in human cancers

Weghorn, D., & Sunyaev, S. R. (2017) · Nature Genetics · doi:10.1038/ng.3987 · Cited by 120

Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types

Giacomini, C. P., Sun, S., Varma, S., Shain, A. H., Giacomini, M. M., Balagtas, J. M. S., Sweeney, R. T., Lai, E., Fitz, C. D. V., Forster, A. D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003464 · Cited by 117

The tandem duplicator phenotype as a distinct genomic configuration in cancer

Menghi, F., Inaki, K., Woo, X., Kumar, P., Grzȩda, K. R., Malhotra, A., Yadav, V. K., Kim, H., Márquez, E. J., Ucar, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520010113 · Cited by 119

Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients

Wang, C., Yin, R. H., Dai, J., Gu, Y., Cui, S., Ma, H., Zhang, Z., Huang, J., Qin, N., Jiang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04492-2 · Cited by 115

Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases

Buljan, M., Ciuffa, R., van Drogen, A., Vichalkovski, A., Mehnert, M., Rosenberger, G., Lee, S., Varjosalo, M. T., Pernas, L. E., Spegg, V., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.001 · Cited by 118

Allele-Specific Amplification in Cancer Revealed by SNP Array Analysis

LaFramboise, T., Weir, B. A., Zhao, X., Beroukhim, R., Li, C., Harrington, D. P., Sellers, W. R., & Meyerson, M. M. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010065 · Cited by 117

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

Tabarés‐Seisdedos, R., & Rubenstein, J. L. R. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3464 · Cited by 118

A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines

Asmann, Y. W., Hossain, A., Necela, B. M., Middha, S., Kalari, K. R., Sun, Z., Chai, H. S., Williamson, D. W., Radisky, D. C., Schroth, G. P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr362 · Cited by 114

Discovering personalized driver mutation profiles of single samples in cancer by network control strategy

Guo, W.-F., Zhang, S., Liu, L., Liu, F., Shi, Q., Zhang, L., Tang, Y. Z., Zeng, T., & Chen, L. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty006 · Cited by 114

High‐resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis

Paulson, V., Chandler, G. L., Rakheja, D., Galindo, R. L., Wilson, K., Amatruda, J. F., & Cameron, S. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20864 · Cited by 114

Better prediction by use of co‐data: adaptive group‐regularized ridge regression

van de Wiel, M. A., Lien, T. G., Verlaat, W., van Wieringen, W. N., & Wilting, S. M. (2015) · Statistics in Medicine · doi:10.1002/sim.6732 · Cited by 116

Loss of heterozygosity: what is it good for?

Ryland, G. L., Doyle, M., Goode, D. L., Boyle, S. E., Choong, D. Y. H., Rowley, S. M., Li, J., Australian Ovarian Cancer Study Group, Bowtell, D. D. L., Tothill, R. W., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0123-z · Cited by 121

Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability

Giehl, M., Fabarius, A. C., Frank, O., Hochhaus, A., Hafner, M., Hehlmann, R., & Seifarth, W. (2005) · Leukemia · doi:10.1038/sj.leu.2403779 · Cited by 114

Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis

Ramakrishna, M., Williams, L. H., Boyle, S. E., Bearfoot, J. L., Sridhar, A., Speed, T. P., Gorringe, K. L., & Campbell, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009983 · Cited by 112

Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling

Bilal, E., Dutkowski, J., Guinney, J., Jang, I. S., Logsdon, B. A., Pandey, G. S., Sauerwine, B., Shimoni, Y., Vollan, H. K. M., Mecham, B. H., et al. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003047 · Cited by 113

Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases

Ng, C. K. Y., Bidard, F., Piscuoglio, S., Geyer, F. C., Lim, R. S., de Bruijn, I., Shen, R., Pareja, F. G., Berman, S., Wang, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3115 · Cited by 112

Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast

Piscuoglio, S., Ng, C. K. Y., Geyer, F. C., Burke, K. A., Cowell, C. F., Martelotto, L. G., Natrajan, R., Popova, T. G., Maher, C. A., Lim, R. S., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0048-0 · Cited by 111

Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features

Lanzós, A., Carlevaro-Fita, J., Mularoni, L., Reverter, F., Palumbo, E., Guigó, R., & Johnson, R. (2017) · Scientific Reports · doi:10.1038/srep41544 · Cited by 111

Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden

Qing, T., Mohsen, H., Marczyk, M., Ye, Y., O’Meara, T. A., Zhao, H., Townsend, J. P., Gerstein, M., Hatzis, C., Kluger, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16293-7 · Cited by 112

The translational challenges of precision oncology

Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 116

Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas

Soung, Y. H., Lee, J. W., Kim, S. Y., Sung, Y. J., Park, W. S., Nam, S. W., Kim, S. H., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2004) · Oncogene · doi:10.1038/sj.onc.1208244 · Cited by 111

Identification of genes with a correlation between copy number and expression in gastric cancer

Cheng, L., Wang, P., Yang, S., Yang, Y., Zhang, Q., Zhang, W., Gao, H., Gao, H., & Zhang, Q. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-14 · Cited by 110

Large-Scale Functional Organization of Long-Range Chromatin Interaction Networks

Sandhu, K. S., Li, G., Poh, H. M., Quek, Y. L. K., Sia, Y. Y., Peh, S. Q., Mulawadi, F. H., Lim, J., Šikić, M., Menghi, F., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.022 · Cited by 113

Role of let-7 family microRNA in breast cancer

Thammaiah, C. K., & Jayaram, S. (2016) · Non-coding RNA Research · doi:10.1016/j.ncrna.2016.10.003 · Cited by 113

LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes

Singh, P. K., Plumb, M. R., Ferris, A. L., Iben, J. R., Wu, X., Fadel, H. J., Luke, B. T., Esnault, C., Poeschla, E. M., Hughes, S. H., et al. (2015) · Genes & Development · doi:10.1101/gad.267609.115 · Cited by 109

Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing

Bodian, D. L., McCutcheon, J. N., Kothiyal, P., Huddleston, K., Iyer, R. K., Vockley, J. G., & Niederhuber, J. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094554 · Cited by 110

Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines

Suzuki, A., Makinoshima, H., Wakaguri, H., Esumi, H., Sugano, S., Kohno, T., Tsuchihara, K., & Suzuki, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku885 · Cited by 109

Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization

Hartmann, S., Martín-Subero, J. I., Gesk, S., Husken, J., Giefing, M., Nagel, I., Riemke, J., Chott, A., Klapper, W., Parrens, M., et al. (2008) · Haematologica · doi:10.3324/haematol.12875 · Cited by 109

Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary

Tothill, R. W., Li, J., Mileshkin, L., Doig, K., Siganakis, T., Cowin, P. A., FELLOWES, A. P., Semple, T. J., Fox, S. B., Byron, K. A., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4251 · Cited by 108

Smad phosphoisoform signaling specificity: the right place at the right time

Matsuzaki, K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr172 · Cited by 114

GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland

Nikiforova, M. N., Nikitski, A. V., Panebianco, F., Kaya, C., Yip, L., Williams, M. D., Chiosea, S. I., Seethala, R. R., Roy, S., Condello, V., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0791 · Cited by 108

GLO1 —A novel amplified gene in human cancer

Santarius, T., Bignell, G. R., Greenman, C., Widaa, S., Chen, L., Mahoney, C., Butler, A. P., Edkins, S., Waris, S., Thornalley, P. J., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20784 · Cited by 107

Characterization of the Drugged Human Genome

Lauss, M., Kriegner, A., Vierlinger, K., & Noehammer, C. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.8.1063 · Cited by 108

A Bioinformatics Workflow for Variant Peptide Detection in Shotgun Proteomics

Li, J., Su, Z., Ma, Z., Slebos, R. J. C., Halvey, P. J., Tabb, D. L., Liebler, D. C., Pao, W. J., & Zhang, B. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.006536 · Cited by 107

Dominating Biological Networks

Milenković, T., Memišević, V., Bonato, A., & Pržulj, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023016 · Cited by 107

Somatic mutations of theERBB4kinase domain in human cancers

Soung, Y. H., Lee, J. W., Kim, S. Y., Wang, Y. P., Jo, K. H., Moon, S. W., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21507 · Cited by 107

Targeting tumor suppressor genes for cancer therapy

Liu, Y., Hu, X., Han, C., Wang, L., Zhang, X., He, X., & Lu, X. (2015) · BioEssays · doi:10.1002/bies.201500093 · Cited by 112

APOBEC3 genes: retroviral restriction factors to cancer drivers

Henderson, S. R., & Fenton, T. R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.007 · Cited by 107

Our changing view of the genomic landscape of cancer

Bell, D. W. (2009) · The Journal of Pathology · doi:10.1002/path.2645 · Cited by 109

Computational Modeling of ERBB2 -Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors

Kirouac, D. C., Du, J. Y., Lahdenranta, J., Overland, R. P., Yarar, D., Paragas, V. B., Pace, E. A., McDonagh, C. F., Nielsen, U. B., & Onsum, M. D. (2013) · Science Signaling · doi:10.1126/scisignal.2004008 · Cited by 107

Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy

Cheng, F., Jia, P., Wang, Q., & Zhao, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.1984 · Cited by 105

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

Cheng, J., Demeulemeester, J., Wedge, D. C., Vollan, H. K. M., Pitt, J. J., Russnes, H. G., Pandey, B. P., Nilsen, G., Nord, S., Bignell, G. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01355-0 · Cited by 106

The LL-100 panel: 100 cell lines for blood cancer studies

Quentmeier, H., Pommerenke, C., Dirks, W. G., Eberth, S., Koeppel, M., MacLeod, R. A. F., Nagel, S., Steube, K. G., Uphoff, C. C., & Drexler, H. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-44491-x · Cited by 114

The current excitement about copy-number variation: how it relates to gene duplications and protein families

Korbel, J. O., Kim, P. M., Chen, X., Urban, A. E., Weissman, S. M., Snyder, M. P., & Gerstein, M. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.02.005 · Cited by 110

Novel aspects of oxidative stress-associated carcinogenesis

Toyokuni, S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1373 · Cited by 104

NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings

An, Ö., Dall’Olio, G. M., Mourikis, T. P., & Ciccarelli, F. D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1123 · Cited by 106

A comprehensive network and pathway analysis of candidate genes in major depressive disorder

Jia, P., Kao, C.-F., Kuo, P., & Zhao, Z. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s3-s12 · Cited by 104

Systematic analysis of somatic mutations impacting gene expression in 12 tumour types

Ding, J., McConechy, M. K., Horlings, H. M., Ha, G., Chan, F. C., Funnell, T., Mullaly, S. C., Reimand, J., Bashashati, A., Bader, G. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9554 · Cited by 108

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

Harbst, K., Lauss, M., Cirenajwis, H., Isaksson, K., Rosengren, F., Törngren, T., Kvist, A., Johansson, M. C., Vallon‐Christersson, J., Baldetorp, B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3476 · Cited by 108

Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors

Segatto, O., Anastasi, S., & Alemà, S. (2011) · Journal of Cell Science · doi:10.1242/jcs.083303 · Cited by 103

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines

Campbell, J., Ryan, C. J., Brough, R., Bajrami, I., Pemberton, H. N., Chong, I. Y.-S., Costa-Cabral, S., Frankum, J. R., Gulati, A., Holme, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.023 · Cited by 104

Application of next‐generation sequencing to improve cancer management: A review of the clinical effectiveness and cost‐effectiveness

Tan, O., Shrestha, R. N., Cunich, M. M., & SCHOFIELD, D. J. (2017) · Clinical Genetics · doi:10.1111/cge.13199 · Cited by 106

The Temporal Order of Genetic and Pathway Alterations in Tumorigenesis

Gerstung, M., Eriksson, N., Lin, J., Vogelstein, B., & Beerenwinkel, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027136 · Cited by 103

Unraveling the clonal hierarchy of somatic genomic aberrations

Prandi, D., Baca, S. C., Romanel, A., Barbieri, C. E., Mosquera, J., Fontugne, J., Beltran, H., Sboner, A., Garraway, L. A., Rubin, M. A., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0439-6 · Cited by 102

Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity

Tan, H., Bao, J., & Zhou, X. (2015) · Scientific Reports · doi:10.1038/srep12566 · Cited by 106

Cancer driver mutations in protein kinase genes

Torkamani, A., Verkhivker, G. M., & Schork, N. J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.008 · Cited by 102

Refining tumor-associated aneuploidy through ‘genomic recoding’ of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas

Thomas, R. J., Seiser, E., Motsinger‐Reif, A. A., Borst, L. B., Valli, V. E., Kelley, K. L., Suter, S. E., Argyle, D. J., Burgess, K. E., Bell, J. S., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.559802 · Cited by 102

Mutation at the Polymerase Active Site of Mouse DNA Polymerase δ Increases Genomic Instability and Accelerates Tumorigenesis

Venkatesan, R. N., Treuting, P. M., Fuller, E. D., Goldsby, R. E., Norwood, T. H., Gooley, T. A., Ladiges, W., Preston, B. D., & Loeb, L. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00002-07 · Cited by 102

Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions

Shugay, M., de Mendíbil, I. O., Vizmanos, J. L., & Novo, F. J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt445 · Cited by 101

Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins

Bohn, J. A., Etten, J. L. V., Schagat, T. L., Bowman, B. M., McEachin, R. C., Freddolino, L., & Goldstrohm, A. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1120 · Cited by 104

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

Piñeiro-Yáñez, E., Reboiro‐Jato, M., Goméz-López, G., Perales-Patón, J., Troulé, K., Rodrı́guez, J. M., Tejero, H., Shimamura, T., Lopez-Casas, P. P., Carretero, J., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0546-1 · Cited by 104

A cloud-based workflow to quantify transcript-expression levels in public cancer compendia

Tatlow, P., & Piccolo, S. (2016) · Scientific Reports · doi:10.1038/srep39259 · Cited by 101

Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response

Sidders, B. S., Zhang, P., Goodwin, K., O’Connor, G., Russell, D. L., Borodovsky, A., Armenia, J., McEwen, R. K., Linghu, B., Bendell, J. C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2183 · Cited by 104

Prediction of Cancer Driver Mutations in Protein Kinases

Torkamani, A., & Schork, N. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5283 · Cited by 102

Role for Amplification and Expression of Glypican-5 in Rhabdomyosarcoma

Williamson, D., Selfe, J., Gordon, T., Lu, Y., Pritchard‐Jones, K., Murai, K., Jones, P. H., Workman, P., & SHIPLEY, J. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1650 · Cited by 101

L1 retrotransposons, cancer stem cells and oncogenesis

Carreira, P. E., Richardson, S. R., & Faulkner, G. J. (2013) · FEBS Journal · doi:10.1111/febs.12601 · Cited by 100

Intercellular competition and the inevitability of multicellular aging

Nelson, P., & Masel, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618854114 · Cited by 103

Interpreting pathways to discover cancer driver genes with Moonlight

Colaprico, A., Olsen, C., Bailey, M. H., Odom, G., Terkelsen, T., Silva, T. C., Olsen, A. V., Cantini, L., Zinovyev, A. Y., Barillot, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13803-0 · Cited by 101

Genome-wide analysis of somatic noncoding mutation patterns in cancer

Dietlein, F., Wang, A. B., Fagre, C. R., Tang, A., Besselink, N. J. M., Cuppen, E. P. J. G., Li, C., Sunyaev, S. R., Neal, J. T., & Allen, E. M. V. (2022) · Science · doi:10.1126/science.abg5601 · Cited by 103

A comparative study of cancer proteins in the human protein-protein interaction network

Sun, J., & Zhao, Z. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s3-s5 · Cited by 103

DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer

Wang, G. P., Garrigue, A., Ciuffi, A., Ronen, K., Leipzig, J. N., Berry, C. C., Lagresle‐Peyrou, C., Benjelloun, F., Hacein‐Bey‐Abina, S., Fischer, A., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn125 · Cited by 104

Quantification of random genomic mutations

Bielas, J. H., & Loeb, L. A. (2005) · Nature Methods · doi:10.1038/nmeth751 · Cited by 99

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

Juškevičius, D., Lorber, T., Gsponer, J. R., Perrina, V., Ruiz, C. F., Stenner, F., Dirnhofer, S., & Tzankov, A. (2016) · Leukemia · doi:10.1038/leu.2016.135 · Cited by 99

Functional variomics and network perturbation: connecting genotype to phenotype in cancer

Yi, S. S., Lin, S., Li, Y., Zhao, W., Mills, G. B., & Sahni, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.8 · Cited by 105

Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies

Frank, M. H., Wilson, B. J., Gold, J. S., & Frank, N. Y. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.080 · Cited by 102

Selecting causal genes from genome-wide association studies via functionally coherent subnetworks

Taşan, M., Musso, G. A., Hao, T., Vidal, M., MacRae, C. A., & Roth, F. P. (2014) · Nature Methods · doi:10.1038/nmeth.3215 · Cited by 102

Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors

Chen, K., Meric‐Bernstam, F., Zhao, H., Zhang, Q. C., Ezzeddine, N., Tang, L.-Y., Qi, Y., Mao, Y., Chen, T., Chong, Z., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.231100 · Cited by 97

BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis

Wan, Q., Dingerdissen, H., Fan, Y., Gulzar, N., Pan, Y., Wu, T.-J., Cheng, Y., Zhang, H., & Mazumder, R. (2015) · Database · doi:10.1093/database/bav019 · Cited by 99

DriverDBv2: a database for human cancer driver gene research

Chung, I., Chen, C., Su, S.-C., Li, C., Wu, K., Wang, H., & Cheng, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1314 · Cited by 97

Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks

de Villavicencio-Díaz, T. N., Rabalski, A. J., & Litchfield, D. W. (2017) · Pharmaceuticals · doi:10.3390/ph10010027 · Cited by 97

Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors

Bard-Chapeau, E. A., Jeyakani, J., Kok, C. H., Müller, J., Chua, B. Q., Gunaratne, J., Batagov, A. O., Jenjaroenpun, P., Kuznetsov, V. A., Wei, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119229109 · Cited by 97

Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damagePreprint

Hill, S. J., Rolland, T., Adelmant, G., Xia, X., Owen, M., Dricot, A., Zack, T. I., Sahni, N., Jacob, Y., Hao, T., et al. (2014) · Genes & Development · doi:10.1101/gad.241620.114 · Cited by 102

ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins

Krassowski, M., Paczkowska, M., Cullion, K., Huang, T., Dzneladze, I., Ouellette, B. F. F., Yamada, J. T., Fradet‐Turcotte, A., & Reimand, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx973 · Cited by 98

Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival

Cajuso, T., Sulo, P., Tanskanen, T. J., Katainen, R., Taira, A., Hänninen, U. A., Kondelin, J., Forsström, L. M., Välimäki, N., Aavikko, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11770-0 · Cited by 96

Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks

Zhu, H., Uusküla-Reimand, L., Isaev, K., Wadi, L., Alizada, A., Shuai, S., Huang, V., Aduluso-Nwaobasi, D., Paczkowska, M., Abd-Rabbo, D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.027 · Cited by 100

Oncogenomics and the development of new cancer therapies

Strausberg, R. L., Simpson, A. J. G., Old, L. J., & Riggins, G. J. (2004) · Nature · doi:10.1038/nature02627 · Cited by 96

Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation

González-Pérez, A., Deu-Pons, J., & López-Bigas, N. (2012) · Genome Medicine · doi:10.1186/gm390 · Cited by 98

Epidemiology, Etiology, and Prevention of Prostate Cancer

Abouassaly, R., Thompson, I. M., Platz, E. A., & Klein, E. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00095-5 · Cited by 96

Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens

Yost, S. E., Smith, E. N., Schwab, R. B., Bao, L., Jung, H., Wang, X., Voest, E. E., Pierce, J. P., Messer, K. S., Parker, B. A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks299 · Cited by 95

Systems-level cancer gene identification from protein interaction network topology applied to melanogenesis-related functional genomics data

Milenković, T., Memišević, V., Ganesan, A. K., & Pržulj, N. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0192 · Cited by 95

Molecular pathway identification using biological network-regularized logistic models

Zhang, W., Wan, Y., Allen, G. I., Pang, K., Anderson, M. L., & Liu, Z. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s8-s7 · Cited by 95

Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes

Sjöblom, T. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f31108 · Cited by 27

Abstract 2469: The COSMIC Cancer Gene Census - a comprehensive study of all mutated cancer-driving genes

Sońdka, Z., Speedy, H. E., Bamford, S., Cole, C. G., Ward, S. A., & Forbes, S. A. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-2469 · Cited by 1

Patterns of somatic mutation in human cancer genomes

Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143

Identification of cancer genes by mutational profiling of tumor genomes

Benvenuti, S., Arena, S., & Bardelli, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.015 · Cited by 26

[Genes associated to cancer].

Peralta-Rodríguez, R., Valdivia, A., Mendoza, M. C., de Rodríguez, J., Marrero–Rodríguez, D., Paniagua, L., Romero, P., Taniguchi, K., & Salcedo, M. (2015) · PubMed · Cited by 2